Jon MarkmanEditor, Trader's Advantage and CounterPoint Options
About Jon Markman
Jon Markman is the editor of Trader’s Advantage, a daily trading service that leverages his unique swing trading principles and aims to capture profits of 7% to 15% — and often much more with his options trades — in less than 90 days. By combining technical analysis with underlying fundamentals, Jon recommends beaten down stocks on the brink of reversal and powerful momentum stocks breaking out to new highs.
In CounterPoint Options Jon helps options traders lock in consistent profits from the volatility that rocks the market. At its heart is a proprietary trading system, Magnitude, that pinpoints indexes or sectors that have reached a critical inflection point — then translates that signal into profitable trades.
CounterPoint Options keeps volatility options trading very simple, focusing on the most popular, highly traded exchange-traded funds (ETFs) that are headed for a key reversal. Magnitude scans the market and allows subscribers to take advantage of these very liquid trading opportunities.
When CounterPoint Options first launched, it was focused solely on trading the VIX, commonly known as the “fear index.” When traders start buying up put options as “portfolio insurance,” the VIX spikes — a phenomenon that we’ll either trade directly, or use to inform our ETF trades on specific slices of the market. Our agile (and highly lucrative) strategy lets us turn volatility into profits… just like professional traders and hedge funds have been doing for years.
CounterPoint Options helps individual traders make steady, consistent profits from a very methodical approach to growing your portfolio in the midst of a turbulent market.
A pioneer in the development of stock-rating systems and screening software, Jon Markman is co-inventor on two Microsoft patents and author of the best-selling books Swing Trading and Online Investing. He was portfolio manager and senior investment strategist at a multi-strategy hedge fund from 2002 to 2005; managing editor and columnist at CNBC on MSN Money from 1997 to 2002; and an editor, investment columnist and investigative reporter at the Los Angeles Times from 1984 to 1997.
Jon won a Gerald Loeb Award for Distinguished Financial Journalism for his columns explaining market chicanery in 2002; Society of Professional Journalists awards for his 2001 reporting on Enron and the post-Sept. 11-investment environment; and was a news editor on the Los Angeles Times staff that won Pulitzer Prizes for spot-news reporting in 1992 and 1994.
A graduate of Duke University and the Columbia University Graduate School of Journalism, Jon speaks frequently on investment topics at conferences nationwide, as well as on TV and radio.
Join InvestorPlace Insights — FREE!
Get actionable advice from our top experts, including the hottest stocks to buy & sell, 401k and retirement tips, market analysis and more!
If bulls can catch sustained momentum in coming weeks, EBAY should roll to a new high, as it has become a high-quality company.
Physicians Realty Trust (DOC) is a $2.8 billion REIT focused on health care facilities leased to doctors, clinics and hospitals.
Amerisafe is pulling back from its uptrend and should trade back to highs and beyond.
Now that other groups have hit all-time highs, the stocks to watch are the previous laggards.
The world of technology is changing before our eyes, and Globant (GLOB) is one of the few companies in the world helping firms adapt.